Daily Market Movement: QuidelOrtho Corporation (QDEL) Sees a 2.10 Increase, Closing at 28.7

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

The closing price of QuidelOrtho Corporation (NASDAQ: QDEL) was $28.7 for the day, up 2.10% from the previous closing price of $28.11. In other words, the price has increased by $2.10 from its previous closing price. On the day, 1.29 million shares were traded. QDEL stock price reached its highest trading level at $28.74 during the session, while it also had its lowest trading level at $27.915.

Ratios:

Our analysis of QDEL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.66 and its Current Ratio is at 1.20. In the meantime, Its Debt-to-Equity ratio is 0.90 whereas as Long-Term Debt/Eq ratio is at 0.76.

On December 11, 2024, Citigroup Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $44 to $50.

On December 10, 2024, Jefferies started tracking the stock assigning a Hold rating and target price of $43.Jefferies initiated its Hold rating on December 10, 2024, with a $43 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 06 ’25 when The Bujarski 2007 Trust U/A Dt bought 100,200 shares for $47.50 per share.

Blaser Brian J. bought 6,033 shares of QDEL for $249,878 on Dec 11 ’24. The President and CEO now owns 6,033 shares after completing the transaction at $41.42 per share. On Dec 09 ’24, another insider, Robert Bujarski, who serves as the Former COO of the company, bought 20,000 shares for $40.40 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, QDEL now has a Market Capitalization of 1940863488 and an Enterprise Value of 4510762496. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.70 while its Price-to-Book (P/B) ratio in mrq is 0.65. Its current Enterprise Value per Revenue stands at 1.632 whereas that against EBITDA is 8.045.

Stock Price History:

The Beta on a monthly basis for QDEL is 0.08, which has changed by -0.13606262 over the last 52 weeks, in comparison to a change of 0.12463009 over the same period for the S&P500. Over the past 52 weeks, QDEL has reached a high of $49.45, while it has fallen to a 52-week low of $23.77. The 50-Day Moving Average of the stock is -3.18%, while the 200-Day Moving Average is calculated to be -24.11%.

Shares Statistics:

QDEL traded an average of 1.49M shares per day over the past three months and 1113130 shares per day over the past ten days. A total of 67.50M shares are outstanding, with a floating share count of 66.58M. Insiders hold about 1.54% of the company’s shares, while institutions hold 111.89% stake in the company. Shares short for QDEL as of 1749772800 were 4065000 with a Short Ratio of 2.73, compared to 1747267200 on 4233388. Therefore, it implies a Short% of Shares Outstanding of 4065000 and a Short% of Float of 10.01.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Earnings Estimates

A comprehensive evaluation of QuidelOrtho Corporation (QDEL) is underway, with the input of 6.0 analysts contributing to its current rating.The consensus estimate for the next quarter is $0.7, with high estimates of $0.76 and low estimates of $0.57.

Analysts are recommending an EPS of between $2.49 and $2.27 for the fiscal current year, implying an average EPS of $2.39. EPS for the following year is $3.22, with 7.0 analysts recommending between $3.33 and $2.95.

Revenue Estimates

It is expected that $90B in revenue will be generated in the current quarter, according to 7 analysts. It ranges from a high estimate of $613.7M to a low estimate of $604.56M. As of the current estimate, QuidelOrtho Corporation’s year-ago sales were $637MFor the next quarter, 7 analysts are estimating revenue of $693.74M. There is a high estimate of $703.8M for the next quarter, whereas the lowest estimate is $677.83M.

A total of 7 analysts have provided revenue estimates for QDEL’s current fiscal year. The highest revenue estimate was $2.74B, while the lowest revenue estimate was $2.7B, resulting in an average revenue estimate of $2.72B. In the same quarter a year ago, actual revenue was $2.78BBased on 8 analysts’ estimates, the company’s revenue will be $2.83B in the next fiscal year. The high estimate is $2.88B and the low estimate is $2.79B.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.